Back to Search
JOSEPH GATHE, M.D.
M.D.
Infectious Disease Physician
NPI: 1366436263IndividualAccepts Medicare
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
F9471(TX)
Education
BAYLOR COLLEGE OF MEDICINE
Class of 1981
Clinical Trials (1)
1
Linked Trials
0
Recruiting
0
With Results
Research & Publications (20)
A once-daily lopinavir/ritonavir-based regimen is noninferior to twice-daily dosing and results in similar safety and tolerability in antiretroviral-naive subjects through 48 weeks.
PMID 19225400·J Acquir Immune Defic Syndr·2009
3-trial
Experience with darunavir in HIV-infected adults enrolled in a US expanded access program: results from a single center.
PMID 18234149·Curr Med Res Opin·2008
3-trial
Efficacy and safety of three doses of tipranavir boosted with ritonavir in treatment-experienced HIV type-1 infected patients.
PMID 17263650·AIDS Res Hum Retroviruses·2007
4-observational
Efficacy of the protease inhibitors tipranavir plus ritonavir in treatment-experienced patients: 24-week analysis from the RESIST-1 trial.
PMID 17051503·Clin Infect Dis·2006
3-trial
Long-term (120-Week) antiviral efficacy and tolerability of fosamprenavir/ritonavir once daily in therapy-naive patients with HIV-1 infection: an uncontrolled, open-label, single-arm follow-on study.
PMID 16861096·Clin Ther·2006
3-trial
SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patients.
PMID 15238771·AIDS·2004
3-trial
Adherence and potency with antiretroviral therapy: a combination for success.
PMID 14703940·J Acquir Immune Defic Syndr·2003
6-review
Antiviral activity of enteric-coated didanosine, stavudine, and nelfinavir versus zidovudine plus lamivudine and nelfinavir.
PMID 12447010·J Acquir Immune Defic Syndr·2002
3-trial
Three HIV-treating physicians express their professional opinions regarding a case scenario.
PMID 11708163·Res Initiat Treat Action·2000
5-case
Modulation of K65R selection by zidovudine inclusion: analysis of HIV resistance selection in subjects with virologic failure receiving once-daily abacavir/lamivudine/zidovudine and tenofovir DF (study COL40263).
PMID 19563238·AIDS Res Hum Retroviruses·2009
3-trial
Predictors of loss of virologic response in subjects who simplified to lopinavir/ritonavir monotherapy from lopinavir/ritonavir plus zidovudine/lamivudine.
PMID 19292590·AIDS Res Hum Retroviruses·2009
4-observational
Safety and efficacy of enfuvirtide in combination with darunavir-ritonavir and an optimized background regimen in treatment-experienced human immunodeficiency virus-infected patients: the below the level of quantification study.
PMID 18809940·Antimicrob Agents Chemother·2008
3-trial
Antiretroviral rounds. Resistance: what you don't know--can it hurt you?
PMID 18661634·AIDS Clin Care·2008
8-other
Resolution of severe cryptosporidial diarrhea with rifaximin in patients with AIDS.
PMID 18580340·J Acquir Immune Defic Syndr·2008
5-case
Health-related quality of life and tolerability in treatment-experienced HIV-1-infected patients on tipranavir versus comparator regimens.
PMID 18389895·Antivir Ther·2008
4-observational
A once-daily lopinavir/ritonavir-based regimen provides noninferior antiviral activity compared with a twice-daily regimen.
PMID 16951643·J Acquir Immune Defic Syndr·2006
4-observational
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial.
PMID 16890834·Lancet·2006
4-observational
Beyond efficacy: the impact of combination antiretroviral therapy on quality of life.
PMID 16164383·AIDS Patient Care STDS·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4900 FANNIN ST
HOUSTON, TX 77004 - Phone
- (713) 526-9821
Quick Facts
- NPI
- 1366436263
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 45
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile